Category: TCTMD Articles

Canakinumab Reduces Heart-Failure Hospitalizations Among Responders: CANTOS Subanalysis

November 15, 2018

Patients with prior MI and elevated high-sensitivity C-reactive protein (hsCRP) see a dose-dependent reduction in heart-failure hospitalization while taking the anti-inflammatory drug canakinumab (Novartis), researchers reported Sunday at the American Heart Association (AHA) 2018 Scientific Sessions in Chicago, IL. The difference between canakinumab and placebo was only significant, however, among patients who achieved on-treatment hsCRP concentrations < 2 mg/L.

Visit Website

iDissection Classification Study to Evaluate Dissection Rate of Flex Dynamic Scoring Catheter

November 09, 2018

VentureMed Group Inc. announced the initiation of a new study to determine if the Flex Dynamic Scoring Catheter reduces dissections and the need for bailout stents in peripheral arteries. The study, entitled “Arterial Dissections Following FLEX Scoring and Adjunctive Balloon Angioplasty: Intravascular Ultrasound Assessment and Correlation with Angiographic Findings,” will utilize intravascular ultrasound (IVUS) to identify the health of the vessel after treatment.

Visit Website

Isolated SAVR Volumes Slide as TAVR Numbers Mount in the US

October 19, 2018

As TAVR volumes in the United States have grown, those of isolated surgical aortic valve replacement (SAVR) have dropped, as have the comorbidities of the patients treated surgically, according to observational data through 2014. Moreover, patient mortality following SAVR has decreased among the highest-volume TAVR centers.

Visit Website
Page 4 of 94«...23456...10152025303540455055...»